Condividi

26/06/2024 - Addus HomeCare Corporation: Amendment to Current Report Form 8 K/A

[X]
Amendment to current report form 8 k/a
8-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 26, 2024 (June 8, 2024)

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-34504 20-5340172

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

6303 Cowboys Way, Suite 600

Frisco, Texas

75034
(Address of principal executive offices) (Zip Code)

(469)535-8200

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box if the Form 8-Kfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12under the Exchange Act (17 CFR 240.14a-12)

Pre-commencementcommunications pursuant to Rule 14d-2(b)under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencementcommunications pursuant to Rule 13e-4(c)under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.001 par value per share ADUS The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2of the Securities Exchange Act of 1934 (§240.12b-2of this chapter).

Emerging growth company. ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

On June 10, 2024, Addus HomeCare Corporation (the "Company") filed a Current Report on Form 8-K(the "Original Form 8-K")with the Securities and Exchange Commission to report that, on June 8, 2024, Addus HealthCare, Inc., an Illinois corporation ("Addus HealthCare"), a wholly-owned subsidiary of the Company, entered into a Stock and Asset Purchase Agreement (the "Purchase Agreement") with Curo Health Services, LLC, a Delaware limited liability company, which does business as Gentiva. This Current Report on Form 8-K/A amends the Original Form 8-K to include Item 9.01 set forth below and to file the Purchase Agreement, which was not filed with the Original Form 8-K. All other disclosures contained in the Original Form 8-K remain unchanged.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:

Exhibit

No.

Description
10.1 Stock and Asset Purchase Agreement, dated June 8, 2024, by and between Addus HomeCare Corporation and Curo Health Services, LLC.
104 Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADDUS HOMECARE CORPORATION
Date: June 26, 2024 By:

/s/ Brian Poff

Brian Poff
Chief Financial Officer

Disclaimer

Addus HomeCare Corporation published this content on 26 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 June 2024 20:16:09 UTC.

MoneyController ti propone anche

Condividi